The development of treatment for the symptoms of Parkinson's disease (PD) has been one of the most notable successes of neurology. Dopaminergic therapies in the form of levodopa, dopamine agonists, or monoamine oxidase B inhibitors significantly improve the characteristic motor symptoms of bradykine
Treatment of motor fluctuations in Parkinson’s disease: recent developments and future directions
✍ Scribed by Ramirez-Zamora, Adolfo; Molho, Eric
- Book ID
- 121852489
- Publisher
- Expert Reviews
- Year
- 2013
- Tongue
- English
- Weight
- 291 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1473-7175
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We read with interest the abstract by Olson et al. (I). They showed that gabapentin improves rigidity, bradykinesia, and tremor in parkinsonism and Parkinson's disease (PD). We administered gabapentin, 900 mg per day, in an open trial to seven nondemented patients with PD who had painful dystonia,
In questioning the diagnosis of a What is it? case (l), Quinn and Hardie (2) state that in their experience linear streaks of increased signal in the putamen on magnetic resonance imaging (MRI) are not seen in Huntington's disease but were seen in four of their cases of neuroacanthocytosis (3). In t
There are some confusing details in the recent Annals article by the Parkinson Study Group (PSG), concerning the use of entacapone.'